Citigroup provided rating and price targets for ProQR Therapeutics stock.
1 report, 1 independent
Updated Jun 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup provided rating and price targets for ProQR Therapeutics stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
Related events
- Analyst coverage for Vornado Realty Trust resulted in rating changes and price target adjustments from firms including Citigroup, Morgan Stanley, and Truist Financial.
- Citigroup, Morgan Stanley, and other firms are issuing research notes, target prices, and performance analyses for Teradyne stock.
- Citigroup, Benchmark, Scotiabank, and Jefferies Financial Group provided financial ratings and analysis on November 1, 2026.
- Affirm received analyst rating updates from Susquehanna and Citigroup, with Benzinga reporting the changes.
- Citigroup reiterated a market outperform rating for Capital Southwest Corporation.